Ulixertinib is a potent ERK1/2 inhibitor. It affects MAPK signaling, by blocking ERK phosphorylation, to induce apoptosis.
Ulixertinib (BVD-523) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Ulixertinib (BVD-523) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.